Steven Weitzman, MD (@drsweitzman1) 's Twitter Profile
Steven Weitzman, MD

@drsweitzman1

MD Anderson faculty in Endocrine Neoplasia specializing in #ThyroidCancer, Thyroid nodules/biopsy, #Parathyroid, Pituitary, & Adrenal disease. Tweets are my own

ID: 809151418817015808

linkhttp://faculty.mdanderson.org/Steven_Weitzman/Default.asp calendar_today14-12-2016 21:41:46

175 Tweet

486 Followers

219 Following

Steven Weitzman, MD (@drsweitzman1) 's Twitter Profile Photo

My wonderful colleague Naifa Busaidy getting the #ATAThyroid2019 off to a great start discussing new developments and challenges in thyroidology. #endcancer

My wonderful colleague <a href="/naifa_busaidy/">Naifa Busaidy</a> getting the #ATAThyroid2019 off to a great start discussing new developments and challenges in thyroidology. #endcancer
Peter WT Pisters, MD (@ppisters) 's Twitter Profile Photo

Our organizational goals during this pandemic have been to: 1) protect our immunocompromised patients 2) ensure the health of our workforce, and 3) protect our community. Here’s how TMC CEOs teamed up to protect 6.9 million residents in our region: click2houston.com/news/investiga…

Peter WT Pisters, MD (@ppisters) 's Twitter Profile Photo

Yes, we have an exceptional partnership among TMC health systems that brings CEOs together in a remarkable collaboration that is designed to protect our community through sharing of data, teaming around supply chain, and partnering with business leaders and elected officials.

Vivek Subbiah, MD (@viveksubbiah) 's Twitter Profile Photo

100 percent of regular ICU beds in Texas Medical Center occupied, but hospitals have space for surge | khou.com x.com/intent/user?sc…

Jennifer Hartwell, MD FACS (@traumamom4) 's Twitter Profile Photo

The most important work I did today generated 0.0 wRVU. I listened. I held a hand. I was an advocate. And these are the 30 most proud moments of my day.

Vivek Subbiah, MD (@viveksubbiah) 's Twitter Profile Photo

👉A Phase 1b Study Evaluating the Safety and Efficacy of Sotorasib , a KRAS G12C Inhibitor, in Combination With Trametinib, a MEK Inhibitor, in KRAS p.G12C Mutated Solid Tumors Suresh S. Ramalingam, MD, FASCO #Targets21 in CRC and #NSCLC 🫁🧬

👉A Phase 1b Study Evaluating the Safety and Efficacy of Sotorasib , a KRAS G12C Inhibitor, in Combination With Trametinib, a MEK Inhibitor, in KRAS p.G12C Mutated Solid Tumors <a href="/RamalingamMD/">Suresh S. Ramalingam, MD, FASCO</a> #Targets21 in CRC and #NSCLC 🫁🧬
Beth Comcowich Garcia (@bethgarciamda) 's Twitter Profile Photo

Do you have a friend or family member undergoing treatment MD Anderson Cancer Center? A great way to support them and other cancer patients is to donate blood. Give their name and they get $25 credit on their bill! #EndCancer

Do you have a friend or family member undergoing treatment <a href="/MDAndersonNews/">MD Anderson Cancer Center</a>? A great way to support them and other cancer patients is to donate blood. Give their name and they get $25 credit on their bill!  #EndCancer